Rachel M. Pearce

1.4k total citations
25 papers, 993 citations indexed

About

Rachel M. Pearce is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Rachel M. Pearce has authored 25 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Rachel M. Pearce's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rachel M. Pearce is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Rachel M. Pearce collaborates with scholars based in United Kingdom, United States and India. Rachel M. Pearce's co-authors include David S. Siscovick, Trivellore E. Raghunathan, Rozenn N. Lemaître, Anthony H. Goldstone, Adele K. Fielding, Nöel Milpied, P Ernst, Sheila Weinmann, Bruce M. Psaty and Thomas D. Rea and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Rachel M. Pearce

24 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel M. Pearce United Kingdom	14	430	198	187	174	162	25	993
Olga Panes Chile	17	413 1.0×	206 1.0×	48 0.3×	79 0.5×	50 0.3×	28	1.1k
Zahit Bolaman Türkiye	15	203 0.5×	102 0.5×	142 0.8×	88 0.5×	36 0.2×	63	803
Clemens Molnar Austria	11	217 0.5×	245 1.2×	201 1.1×	52 0.3×	37 0.2×	14	1.2k
Charis Matsouka Greece	14	623 1.4×	183 0.9×	230 1.2×	112 0.6×	26 0.2×	37	932
Cecily Forsyth Australia	15	392 0.9×	82 0.4×	72 0.4×	123 0.7×	21 0.1×	57	908
P. H. Pinkerton Canada	18	437 1.0×	25 0.1×	81 0.4×	85 0.5×	55 0.3×	71	1.1k
Afroditi Katsaraki Greece	15	195 0.5×	65 0.3×	133 0.7×	50 0.3×	35 0.2×	32	943
Daniel Lechner Austria	18	152 0.4×	93 0.5×	185 1.0×	366 2.1×	28 0.2×	35	839
Levent Ündar Türkiye	14	286 0.7×	49 0.2×	132 0.7×	44 0.3×	30 0.2×	55	627
Maria Cecília S. Freitas United States	17	211 0.5×	481 2.4×	76 0.4×	66 0.4×	45 0.3×	21	1.6k

Countries citing papers authored by Rachel M. Pearce

Since Specialization

Citations

This map shows the geographic impact of Rachel M. Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Pearce more than expected).

Fields of papers citing papers by Rachel M. Pearce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel M. Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Pearce. The network helps show where Rachel M. Pearce may publish in the future.

Co-authorship network of co-authors of Rachel M. Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M. Pearce. A scholar is included among the top collaborators of Rachel M. Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M. Pearce. Rachel M. Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayor, Neema P., Richard Szydlo, Jungwha Lee, et al.. (2024). The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experience. The Lancet Haematology. 11(12). e916–e926.

Eyre, Toby A., Sally F. Barrington, Jessica Okosun, et al.. (2022). Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation. Haematologica. 108(3). 785–796. 3 indexed citations

Parrish, Christopher, Amin Rahemtulla, Jim Cavet, et al.. (2015). Autologous Stem Cell Transplantation Is an Effective Salvage Therapy for Primary Refractory Multiple Myeloma. Biology of Blood and Marrow Transplantation. 21(7). 1330–1334. 6 indexed citations

Marsh, Judith, Rachel M. Pearce, Mickey Koh, et al.. (2013). Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 49(1). 42–48. 56 indexed citations

Krishnamurthy, Pramila, Victoria Potter, Linda D. Barber, et al.. (2012). Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 19(4). 562–568. 62 indexed citations

Snowden, John A., Rachel M. Pearce, Julia Lee, et al.. (2012). Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997–2009. British Journal of Haematology. 157(6). 742–746. 22 indexed citations

Shaw, Bronwen E., Jane F. Apperley, Nigel H. Russell, et al.. (2011). Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease. British Journal of Haematology. 153(2). 244–252. 14 indexed citations

Patel, Bijendra, Keiren Kirkland, Richard Szydlo, et al.. (2009). Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. Haematologica. 94(10). 1399–1406. 29 indexed citations

Shaw, Bronwen E., G J Mufti, Stephen Mackinnon, et al.. (2008). Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplantation. 42(12). 783–789. 76 indexed citations

10.

Das‐Gupta, Emma, Nigel H. Russell, Bronwen E. Shaw, Rachel M. Pearce, & Jenny Byrne. (2007). Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab. Biology of Blood and Marrow Transplantation. 13(6). 724–733. 11 indexed citations

11.

Chantry, Andrew, John A. Snowden, Charles Craddock, et al.. (2006). Long-Term Outcomes of Myeloablation and Autologous Transplantation of Relapsed Acute Myeloid Leukemia in Second Remission: A British Society of Blood and Marrow Transplantation Registry Study. Biology of Blood and Marrow Transplantation. 12(12). 1310–1317. 11 indexed citations

12.

Cook, Gordon, Richard E. Clark, Charles Crawley, et al.. (2006). The Outcome of Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia in First Remission Who Were Initially Refractory to First Induction Chemotherapy. Biology of Blood and Marrow Transplantation. 12(3). 293–300. 7 indexed citations

13.

Whitsel, Eric A., Edward J. Boyko, Pentti M. Rautaharju, et al.. (2005). Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients. Diabetes Care. 28(8). 2045–2047. 39 indexed citations

14.

Rea, Thomas D., Rachel M. Pearce, Trivellore E. Raghunathan, et al.. (2004). Incidence of Out-of-Hospital cardiac arrest. The American Journal of Cardiology. 93(12). 1455–1460. 124 indexed citations

15.

Rea, Thomas D., David S. Siscovick, Bruce M. Psaty, et al.. (2003). Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure. Journal of Clinical Epidemiology. 56(7). 646–650. 10 indexed citations

16.

Lemaître, Rozenn N., David S. Siscovick, Bruce M. Psaty, et al.. (2002). Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest. The American Journal of Medicine. 113(9). 711–716. 32 indexed citations

17.

Reiner, Alexander P., Frits R. Rosendaal, Pieter H. Reitsma, et al.. (2002). Factor V leiden, prothrombin g20210a, and risk of sudden coronary death in apparently healthy persons. The American Journal of Cardiology. 90(1). 66–68. 13 indexed citations

18.

Lemaître, Rozenn N., Irena B. King, Trivellore E. Raghunathan, et al.. (2002). Cell Membrane Trans -Fatty Acids and the Risk of Primary Cardiac Arrest. Circulation. 105(6). 697–701. 164 indexed citations

19.

Reiner, Alexander P., Stephen M. Schwartz, Frits R. Rosendaal, et al.. (2001). Platelet glycoprotein IIb polymorphism, traditional risk factors and non‐fatal myocardial infarction in young women. British Journal of Haematology. 112(3). 632–636. 26 indexed citations

20.

Gallivan, S, Rachel M. Pearce, & R. R. P. Jackson. (1993). Patient progress modelling for small cell lung cancer. European Journal of Cancer. 29(5). 734–737. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact